DVL2 and glioblastoma: This prompted us to investigate Transforming Growth Factor Beta 1 (TGFB1) and Dishevelled2 (DVL2) in detail, as these were the most promising predicted targets of miR-744 with respect to a supposed role in GBM migration [13,14].